Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Insulet (PODD)
NASDAQ:PODD
Holding PODD?
Track your performance easily
Earnings Data
Report Date
Feb 20, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
1Last Year’s EPS
1.44Same Quarter Last Year
Strong Buy
Based on 14 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 01, 2018
|% Change Since: 12.58%
|Next Earnings Date:Aug 02, 2018
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook for Insulet with significant achievements in revenue growth and market expansion, particularly with the Omnipod 5's entry into the type 2 diabetes market. Despite some challenges in U.S. revenue growth and anticipated retention issues in certain type 2 segments, the company's strategic advancements and international success position it well for continued growth.Company Guidance
During Insulet Corporation's Q3 2024 earnings call, the company provided optimistic guidance, projecting over $2 billion in full-year revenue for the first time. The strong quarter was marked by a 25% revenue growth, driven by a 26% growth in total Omnipod revenue, with the U.S. and international markets growing by 23% and 35%, respectively. Insulet highlighted significant milestones, including FDA clearance for Omnipod 5's type 2 diabetes label expansion, which contributed over 25% of new customer starts in the U.S. in Q3. The company anticipates sustained momentum, expecting 12% to 15% total company growth in Q4 and raising full-year guidance for total Omnipod revenue growth to between 21% and 22%. Gross margin improved to 69.3%, with operating margin at 16.2% and adjusted EBITDA at 23.2%. Insulet plans to continue investing in expanding its sales force and commercial relationships to capitalize on the type 2 diabetes market opportunity.Record Revenue Achievement
Insulet is on track to generate over $2 billion in full-year revenue for the first time in its history.
Omnipod 5 Type 2 Diabetes Market Expansion
FDA clearance for type 2 label expansion for Omnipod 5, making it the first and only AID system indicated for both type 1 and type 2 diabetes. Type 2 users represented over 25% of U.S. new customer starts in Q3.
Strong International Growth
International Omnipod revenue growth of 35% driven by strong demand for Omnipod 5, particularly in the UK, Germany, France, and the Netherlands.
Gross Margin and Profitability Improvement
Gross margin increased to 69.3%, up 150 basis points. Operating margin and adjusted EBITDA exceeded expectations, driven by strong revenue and gross margin performance.
Omnipod 5's Market Leadership in Europe
Omnipod 5 is now the #1 insulin pump for new pump users in Europe, gaining significant traction in multiple markets.
---
PODD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PODD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $244.98 | $268.00 | +9.40% |
| Aug 08, 2024 | $199.79 | $182.19 | -8.81% |
| May 09, 2024 | $177.53 | $165.90 | -6.55% |
| Feb 22, 2024 | $197.14 | $184.21 | -6.56% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Insulet (PODD) report earnings?
Insulet (PODD) is schdueled to report earning on Feb 20, 2025, TBA Not Confirmed.
What is Insulet (PODD) earnings time?
Insulet (PODD) earnings time is at Feb 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PODD EPS forecast?
PODD EPS forecast for the fiscal quarter 2024 (Q4) is 1.
---